The treatment, approved in January, is the first generic of Advair to hit the market. It will be priced between $93.71 and $153.14.
The FDA didn’t approve Advair generics from Novartis and Hikma Pharmaceuticals.
More articles on pharmacy:
Better pharmacy access sought for rural Colorado residents
Following its rival, Sanofi and Regeneron slash price of cholesterol drug by 60%
Mount Carmel’s chief pharmacy officer out amid overprescribing scandal
Next Up in Pharmacy
-
Author’s note: The concepts described herein are intended as a strategic framework rather than a prescriptive operating model. Health systems…
-
UnitedHealth Group’s pharmacy benefit manager, Optum Rx, has launched three digital tools for members, building on its model designed for…
-
Maryland’s Prescription Drug Affordability Board voted unanimously Nov. 16 to approve final regulations setting upper payment limits on Novo Nordisk’s…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.